UroGen Pharma
URGN
URGN
101 hedge funds and large institutions have $248M invested in UroGen Pharma in 2023 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 35 increasing their positions, 22 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
19% more funds holding
Funds holding: 85 → 101 (+16)
2.2% more ownership
Funds ownership: 56.33% → 58.53% (+2.2%)
Holders
101
Holding in Top 10
1
Calls
$1.04M
Puts
$509K
Top Buyers
| 1 | +$36.7M | |
| 2 | +$20.8M | |
| 3 | +$7.13M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$5.21M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.91M |
Top Sellers
| 1 | -$4.64M | |
| 2 | -$4.3M | |
| 3 | -$3.5M | |
| 4 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
-$3.18M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$2.96M |